Local Adverse Reactions Decreased Over Time During Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (FSCIG) Treatment in Patients with PID

被引：0

作者：

Stein, Mark ^{[1
]}

Wasserman, Richard L. ^{[2
]}

Melamed, Isaac ^{[3
]}

Gupta, Sudhir ^{[4
]}

Kobrynski, Lisa ^{[5
]}

Rubinstein, Arye ^{[6
,7
]}

Rabbat, Christopher J. ^{[8
]}

Engl, Werner ^{[9
]}

McCoy, Barbara ^{[10
]}

Leibl, Heinz ^{[9
]}

Yel, Leman ^{[10
]}

机构：

[1] Allergy Associates Palm Beaches, North Palm Beach, FL USA

[2] Allergy Partners North Texas Res, Dallas, TX USA

[3] IMMUNOe Hlth Ctr, Centennial, CO USA

[4] Univ Calif Irvine, Irvine, CA USA

[5] Emory Univ, Atlanta, GA 30322 USA

[6] Albert Einstein Coll Med, Bronx, NY 10467 USA

[7] Montefiore Hosp, Bronx, NY USA

[8] Shire, Chicago, IL USA

[9] Shire, Vienna, Austria

[10] Shire, Cambridge, MA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2017年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

PO - 136

引用

页码：S54 / S54

页数：1

共 43 条

[1] Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies
Stein, Mark R.
Wasserman, Richard L.
Melamed, Isaac
Gupta, Sudhir
Kobrynski, Lisa J.
Rubinstein, Arye
Rabbat, Christopher J.
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
[2] LOCAL ADVERSE REACTION RATES DECREASED OVER TIME DURING RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G (IgG) (IGHy) TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISORDERS (PIDD) IN THE IGHy PHASE 3 STUDIES
Stein, Mark
Wasserman, Richard L.
Melamed, Isaac
Gupta, Sudhir
Kobrynski, Lisa
Rubenstein, Arye
Rabbat, Christopher
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 269 - 270
[3] EFFICACY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G (IGHy) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES: INFECTIONS OVER TIME
Wasserman, Richard L.
Stein, Mark
Kobrynski, Lisa
Gupta, Sudhir
Grant, J. Andrew
Rubenstein, Arye
Rabbat, Christopher
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 268 - 269
[4] Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
Wasserman, Richard L.
IMMUNOTHERAPY, 2017, 9 (12) : 1035 - 1050
[5] Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients
van Paassen, Pieter
Pittrow, David
Scheidegger, Clemens
Klotsche, Jens
Ellerbroek, Pauline M.
IMMUNOTHERAPY, 2020, 12 (02) : 131 - 139
[6] Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (IGHy) in Patients with Primary Immunodeficiency Disease (PIDD): Infections over Time
Wasserman, Richard L.
Stein, Mark R.
Kobrynski, Lisa J.
Gupta, Sudhir
Grant, J. Andrew
Rubinstein, Arye
Rabbat, Christopher J.
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB219 - AB219
[7] Long-Term Efficacy, Adverse Events, and Tolerability of Recombinant Human Hyaluronidase -Facilitated Subcutaneous Infusion of Immunoglobulin G (FSCIG) in Patients Aged <18 Years with Primary Immunodeficiency Diseases (PID)
Wasserman, Richard L.
Melamed, Isaac
Stein, Mark
Kobrynski, Lisa
Gupta, Sudhir
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S53 - S54
[8] REAL WORLD EXPERIENCE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN IN COMMON VARIABLE IMMUNODEFICIENCY
Pinna, K.
Moffitt, K.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S94 - S94
[9] EFFICACY, SAFETY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: PHASE 3 STUDY RESULTS
Stein, Mark
Wasserman, Richard L.
Melamed, Isaac
Rubinstein, Arye
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
McCoy, Barbara
Yel, Leman
Schiff, Richard I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 727 - 727
[10] Long-Term Efficacy, Adverse Events, and Tolerability of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G in Patients Aged ≥18 Years with Primary Immunodeficiency Diseases
Wasserman, Richard L.
Stein, Mark
Kobrynski, Lisa
Gupta, Sudhir
Grant, J. Andrew
Rubinstein, Arye
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S53 - S53

← 1 2 3 4 5 →